Self-injectable Epinephrine for First-Aid Management of Anaphylaxis
Authors:
- Scott H. SichererSSScott H. Sicherer
- F. Estelle R. SimonsFSF. Estelle R. Simons
- The Section On Allergy And ImmunologyTIThe Section On Allergy And Immunology
- 1 March 2007
- journal article
- practice guideline
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 119 (3) , 638-646
Abstract
This Clinical Report was revised. See https://doi.org/10.1542/peds.2016-4006.: Anaphylaxis is a severe, potentially fatal systemic allergic reaction that is rapid in onset and may cause death. Epinephrine is the primary medical therapy, and it must be administered promptly. This clinical report focuses on practical issues concerning the administration of self-injectable epinephrine for first-aid treatment of anaphylaxis in the community. The recommended epinephrine dose for anaphylaxis in children, based primarily on anecdotal evidence, is 0.01 mg/kg, up to 0.30 mg. Intramuscular injection of epinephrine into the lateral thigh (vastus lateralis) is the preferred route for therapy in first-aid treatment. Epinephrine autoinjectors are currently available in only 2 fixed doses: 0.15 and 0.30 mg. On the basis of current, albeit limited, data, it seems reasonable to recommend autoinjectors with 0.15 mg of epinephrine for otherwise healthy young children who weigh 10 to 25 kg (22–55 lb) and autoinjectors with 0.30 mg of epinephrine for those who weigh approximately 25 kg (55 lb) or more; however, specific clinical circumstances must be considered in these decisions. This report also describes several quandaries in regard to management, including the selection of dose, indications for prescribing an autoinjector, and decisions regarding when to inject epinephrine. Effective care for individuals at risk of anaphylaxis requires a comprehensive management approach involving families, allergic children, schools, camps, and other youth organizations. Risk reduction entails confirmation of the trigger, discussion of avoidance of the relevant allergen, a written individualized emergency anaphylaxis action plan, and education of supervising adults with regard to recognition and treatment of anaphylaxis.Keywords
This publication has 42 references indexed in Scilit:
- Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxisJournal of Allergy and Clinical Immunology, 2006
- Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaignClinical & Experimental Allergy, 2005
- Management of adrenaline (epinephrine) induced digital ischaemia in children after accidental injection from an EpiPenEmergency Medicine Journal, 2004
- First-aid treatment of anaphylaxis to food: Focus on epinephrineJournal of Allergy and Clinical Immunology, 2004
- Real-Time reporting of anaphylaxis in infants, children and adolescents by physicians involved in the canadian pediatric surveillance programJournal of Allergy and Clinical Immunology, 2002
- Epinephrine absorption in adults: Intramuscular versus subcutaneous injectionJournal of Allergy and Clinical Immunology, 2001
- Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based studyAnnals of Allergy, Asthma & Immunology, 2001
- Self-injectable epinephrine: no size fits all!Annals of Allergy, Asthma & Immunology, 2001
- A Retrospective Study of Epinephrine Administration for Anaphylaxis: How Many Doses Are Needed?Allergy and Asthma Proceedings, 1999
- Anaphylaxis in schools and other child-care settingsJournal of Allergy and Clinical Immunology, 1998